US HB1736 | 2017-2018 | 115th Congress
Status
Spectrum: Slight Partisan Bill (Republican 6-3)
Status: Introduced on March 27 2017 - 25% progression, died in committee
Action: 2017-03-31 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 27 2017 - 25% progression, died in committee
Action: 2017-03-31 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. This bill amends the Federal Food, Drug, and Cosmetic Act to revise provisions regarding Food and Drug Administration (FDA): (1) inspections of establishments that manufacture or process medical devices, and (2) certification of medical devices for export. The biannual inspection schedule for medical device establishments handling higher risk devices is replaced with a risk-based schedule. In establishing the risk-based schedule, the FDA must consider an establishment's participation in international medical device audit programs. The FDA must adopt a uniform process and uniform standards for inspections of domestic and foreign medical device establishments. Upon request, the FDA must provide to the person in charge of a medical device establishment feedback regarding the person's proposals to address issues identified during an inspection. The FDA must provide the basis for denying requests for certification of products for export as meeting FDA requirements for domestic products. A person denied such a certification may request supervisory review of that decision. Products from a medical device establishment that an inspector found to be contaminated or insanitary may be certified for export if the person in charge of the establishment has agreed to a plan to correct the issues identified during the inspection.
Title
To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.
Sponsors
Rep. Larry Bucshon [R-IN] | Rep. Susan Brooks [R-IN] | Rep. Scott Peters [D-CA] | Rep. G. Butterfield [D-NC] |
Sen. Marsha Blackburn [R-TN] | Rep. Jim Banks [R-IN] | Rep. Richard Hudson [R-NC] | Rep. Todd Rokita [R-IN] |
Rep. Josh Gottheimer [D-NJ] |
History
Date | Chamber | Action |
---|---|---|
2017-03-31 | House | Referred to the Subcommittee on Health. |
2017-03-27 | House | Referred to the House Committee on Energy and Commerce. |
2017-03-27 | House | Introduced in House |
Same As/Similar To
SB404 (Same As) 2017-02-15 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Administrative law and regulatory procedures
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Health
Health technology, devices, supplies
Manufacturing
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Health
Health technology, devices, supplies
Manufacturing
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/115th-congress/house-bill/1736/all-info |
Text | https://www.congress.gov/115/bills/hr1736/BILLS-115hr1736ih.pdf |